_id
6911c643ccc777a4e85d6562
Ticker
HNGZY
Name
Hangzhou Tigermed Consulting Co. Ltd
Exchange
PINK
Address
Shengda Science Park, Building A, Hangzhou, China, 310051
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.tigermedgrp.com
Description
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. It operates through Clinical Trial Solutions; and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. In addition, the company offers patient recruitment, investment management, medical registration, pharmaceuticals and regulations consulting, drug safety, bioequivalence, and third-party training services, as well as chemistry, management, and controls services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Last Close
4
Volume
-
Current Price
4
Change
0
Last Updated
2026-01-04T14:35:12.395Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
3444104192
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
248053898
Cost Of Revenue
179923440
Gross Profit
68130457
Operating Expenses
44653150
Operating Income
23477306
Interest Expense
1799126
Pretax Income
108990708
Net Income
89012203
Eps
0.10337922180170972
Dividends Per Share
-
Shares Outstanding
123124800
Income Tax Expense
7158810
EBITDA
110789836
Operating Margin
9.4645986978201
Total Other Income Expense Net
85513402
Cash
231532109
Short Term Investments
8147841
Receivables
618709118
Inventories
6173105
Total Current Assets
892132529
Property Plant Equipment
229626218
Total Assets
4043612273
Payables
47472483
Short Term Debt
114781014
Long Term Debt
-
Total Liabilities
572689066
Equity
2974852483
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
66248527
Capital Expenditures
10168647
Cash From Investing
35696624
Cash From Financing
-113227744
Net Change In Cash
-5162945
Cf_currency_symbol
-
PE
26.6667
PB
1.1577394911786623
ROE
2.9921551911789366
ROA
2.201304106092271
FCF
56079880
Fcf Percent
0.22607941440210708
Piotroski FScore
3
Health Score
73
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
9.3
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
5
Net Net Investing Score
4
Quality Investing Score
8
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
248053898
Quarters > 0 > income Statement > cost Of Revenue
179923440
Quarters > 0 > income Statement > gross Profit
68130457
Quarters > 0 > income Statement > operating Expenses
44653150
Quarters > 0 > income Statement > operating Income
23477306
Quarters > 0 > income Statement > interest Expense
1799126
Quarters > 0 > income Statement > pretax Income
108990708
Quarters > 0 > income Statement > net Income
89012203
Quarters > 0 > income Statement > eps
0.10337922180170972
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
861026050
Quarters > 0 > income Statement > income Tax Expense
7158810
Quarters > 0 > income Statement > EBITDA
110789836
Quarters > 0 > income Statement > operating Margin
9.4645986978201
Quarters > 0 > income Statement > total Other Income Expense Net
85513402
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
231532109
Quarters > 0 > balance Sheet > short Term Investments
8147841
Quarters > 0 > balance Sheet > receivables
618709118
Quarters > 0 > balance Sheet > inventories
6173105
Quarters > 0 > balance Sheet > total Current Assets
892132529
Quarters > 0 > balance Sheet > property Plant Equipment
229626218
Quarters > 0 > balance Sheet > total Assets
4043612273
Quarters > 0 > balance Sheet > payables
47472483
Quarters > 0 > balance Sheet > short Term Debt
114781014
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
572689066
Quarters > 0 > balance Sheet > equity
2974852483
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
89012203
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
66248527
Quarters > 0 > cash Flow > capital Expenditures
10168647
Quarters > 0 > cash Flow > cash From Investing
35696624
Quarters > 0 > cash Flow > cash From Financing
-113227744
Quarters > 0 > cash Flow > net Change In Cash
-5162945
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.10337922180170972
Quarters > 0 > ratios > PB
1.1577394911786623
Quarters > 0 > ratios > ROE
2.9921551911789366
Quarters > 0 > ratios > ROA
2.201304106092271
Quarters > 0 > ratios > FCF
56079880
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.22607941440210708
Quarters > 0 > health Score
73
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1686300664
Quarters > 1 > income Statement > cost Of Revenue
1178083100
Quarters > 1 > income Statement > gross Profit
508217564
Quarters > 1 > income Statement > operating Expenses
208464086
Quarters > 1 > income Statement > operating Income
299753478
Quarters > 1 > income Statement > interest Expense
16724711
Quarters > 1 > income Statement > pretax Income
299063992
Quarters > 1 > income Statement > net Income
217868392
Quarters > 1 > income Statement > eps
0.2501680626337818
Quarters > 1 > income Statement > dividends Per Share
-244442211
Quarters > 1 > income Statement > shares Outstanding
870888113
Quarters > 1 > income Statement > income Tax Expense
46216536
Quarters > 1 > income Statement > EBITDA
309709463
Quarters > 1 > income Statement > operating Margin
17.77580264298585
Quarters > 1 > income Statement > total Other Income Expense Net
-689485
Quarters > 1 > income Statement > currency_symbol
CNY
Quarters > 1 > balance Sheet > cash
1732879415
Quarters > 1 > balance Sheet > short Term Investments
87000000
Quarters > 1 > balance Sheet > receivables
4158130588
Quarters > 1 > balance Sheet > inventories
43634437
Quarters > 1 > balance Sheet > total Current Assets
6206460726
Quarters > 1 > balance Sheet > property Plant Equipment
1671159528
Quarters > 1 > balance Sheet > total Assets
28504657758
Quarters > 1 > balance Sheet > payables
313002724
Quarters > 1 > balance Sheet > short Term Debt
1439391704
Quarters > 1 > balance Sheet > long Term Debt
556783178.07
Quarters > 1 > balance Sheet > total Liabilities
4540955401
Quarters > 1 > balance Sheet > equity
20524441879
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
217868392.41
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-218974644
Quarters > 1 > cash Flow > cash From Operations
210684393
Quarters > 1 > cash Flow > capital Expenditures
52736603.2
Quarters > 1 > cash Flow > cash From Investing
703759294
Quarters > 1 > cash Flow > cash From Financing
-723084514
Quarters > 1 > cash Flow > net Change In Cash
200759833
Quarters > 1 > cash Flow > currency_symbol
CNY
Quarters > 1 > ratios > PE
0.2501680626337818
Quarters > 1 > ratios > PB
0.16972702461469938
Quarters > 1 > ratios > ROE
1.0615070231113883
Quarters > 1 > ratios > ROA
0.7643255844348945
Quarters > 1 > ratios > FCF
157947789.8
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.09366525980327789
Quarters > 1 > health Score
58
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1564143614
Quarters > 2 > income Statement > cost Of Revenue
1094382708
Quarters > 2 > income Statement > gross Profit
469760906
Quarters > 2 > income Statement > operating Expenses
325256523
Quarters > 2 > income Statement > operating Income
144504382
Quarters > 2 > income Statement > interest Expense
31748445
Quarters > 2 > income Statement > pretax Income
143625342
Quarters > 2 > income Statement > net Income
165468741
Quarters > 2 > income Statement > eps
0.18999999946032103
Quarters > 2 > income Statement > dividends Per Share
-27059863
Quarters > 2 > income Statement > shares Outstanding
870888113
Quarters > 2 > income Statement > income Tax Expense
33644494
Quarters > 2 > income Statement > EBITDA
187381809
Quarters > 2 > income Statement > operating Margin
9.23856228460106
Quarters > 2 > income Statement > total Other Income Expense Net
-879040
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1505267395
Quarters > 2 > balance Sheet > short Term Investments
170000000
Quarters > 2 > balance Sheet > receivables
3994827230
Quarters > 2 > balance Sheet > inventories
36463701
Quarters > 2 > balance Sheet > total Current Assets
5895369481
Quarters > 2 > balance Sheet > property Plant Equipment
1669475917
Quarters > 2 > balance Sheet > total Assets
28729592949
Quarters > 2 > balance Sheet > payables
277367516
Quarters > 2 > balance Sheet > short Term Debt
1890046526
Quarters > 2 > balance Sheet > long Term Debt
581674789.07
Quarters > 2 > balance Sheet > total Liabilities
4820982910
Quarters > 2 > balance Sheet > equity
20529274699
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
165468744
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
197934614
Quarters > 2 > cash Flow > capital Expenditures
48094554
Quarters > 2 > cash Flow > cash From Investing
-657869238
Quarters > 2 > cash Flow > cash From Financing
-103865806.5
Quarters > 2 > cash Flow > net Change In Cash
-558841014
Quarters > 2 > cash Flow > currency_symbol
CNY
Quarters > 2 > ratios > PE
0.18999999946032103
Quarters > 2 > ratios > PB
0.16968706898201755
Quarters > 2 > ratios > ROE
0.8060135753751696
Quarters > 2 > ratios > ROA
0.5759522639034103
Quarters > 2 > ratios > FCF
149840060
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.09579686843256836
Quarters > 2 > health Score
59
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1535504802
Quarters > 3 > income Statement > cost Of Revenue
1263773522
Quarters > 3 > income Statement > gross Profit
271731280
Quarters > 3 > income Statement > operating Expenses
692308169
Quarters > 3 > income Statement > operating Income
-420576889.38
Quarters > 3 > income Statement > interest Expense
24717445.18
Quarters > 3 > income Statement > pretax Income
-422603463.45
Quarters > 3 > income Statement > net Income
-408285423.64
Quarters > 3 > income Statement > eps
-0.4736449013132577
Quarters > 3 > income Statement > dividends Per Share
-33301746.32
Quarters > 3 > income Statement > shares Outstanding
862007429
Quarters > 3 > income Statement > income Tax Expense
32700726
Quarters > 3 > income Statement > EBITDA
-288345451.34
Quarters > 3 > income Statement > operating Margin
-27.390138333152542
Quarters > 3 > income Statement > total Other Income Expense Net
-2026574.07
Quarters > 3 > income Statement > currency_symbol
CNY
Quarters > 3 > balance Sheet > cash
2055344830
Quarters > 3 > balance Sheet > short Term Investments
74852975
Quarters > 3 > balance Sheet > receivables
3959489385
Quarters > 3 > balance Sheet > inventories
31956085
Quarters > 3 > balance Sheet > total Current Assets
6299685225
Quarters > 3 > balance Sheet > property Plant Equipment
1686264056
Quarters > 3 > balance Sheet > total Assets
28671015787
Quarters > 3 > balance Sheet > payables
257287412
Quarters > 3 > balance Sheet > short Term Debt
1912017204
Quarters > 3 > balance Sheet > long Term Debt
323649635.25
Quarters > 3 > balance Sheet > total Liabilities
4606536600
Quarters > 3 > balance Sheet > equity
20670653449
Quarters > 3 > balance Sheet > currency_symbol
CNY
Quarters > 3 > cash Flow > net Income
-408285423.64
Quarters > 3 > cash Flow > depreciation
132231438
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
78492755.15
Quarters > 3 > cash Flow > cash From Investing
983994485
Quarters > 3 > cash Flow > cash From Financing
-1430408541.68
Quarters > 3 > cash Flow > net Change In Cash
86606996
Quarters > 3 > cash Flow > currency_symbol
CNY
Quarters > 3 > ratios > PE
-0.4736449013132577
Quarters > 3 > ratios > PB
0.16680796881952503
Quarters > 3 > ratios > ROE
-1.9751935982447226
Quarters > 3 > ratios > ROA
-1.4240354324143778
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
6603120162
Annuals > 0 > income Statement > cost Of Revenue
4361106945
Annuals > 0 > income Statement > gross Profit
2242013217
Annuals > 0 > income Statement > operating Expenses
1577594205
Annuals > 0 > income Statement > operating Income
664419011
Annuals > 0 > income Statement > interest Expense
141235382
Annuals > 0 > income Statement > pretax Income
664461508
Annuals > 0 > income Statement > net Income
405143491
Annuals > 0 > income Statement > eps
0.4699999992691478
Annuals > 0 > income Statement > dividends Per Share
-642156083
Annuals > 0 > income Statement > shares Outstanding
862007429
Annuals > 0 > income Statement > income Tax Expense
216630221
Annuals > 0 > income Statement > EBITDA
1129837129
Annuals > 0 > income Statement > operating Margin
10.062197789821168
Annuals > 0 > income Statement > total Other Income Expense Net
42497
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2055344830
Annuals > 0 > balance Sheet > short Term Investments
74852975
Annuals > 0 > balance Sheet > receivables
3959489385
Annuals > 0 > balance Sheet > inventories
31956085
Annuals > 0 > balance Sheet > total Current Assets
6299685225
Annuals > 0 > balance Sheet > property Plant Equipment
1686264056
Annuals > 0 > balance Sheet > total Assets
28671015787
Annuals > 0 > balance Sheet > payables
257287412
Annuals > 0 > balance Sheet > short Term Debt
1912017204
Annuals > 0 > balance Sheet > long Term Debt
323649635.25
Annuals > 0 > balance Sheet > total Liabilities
4606536600
Annuals > 0 > balance Sheet > equity
20670653449
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
447831286
Annuals > 0 > cash Flow > depreciation
324140239
Annuals > 0 > cash Flow > change In Working Capital
-268472206
Annuals > 0 > cash Flow > cash From Operations
1097001903
Annuals > 0 > cash Flow > capital Expenditures
356554496
Annuals > 0 > cash Flow > cash From Investing
-4739122414
Annuals > 0 > cash Flow > cash From Financing
-1702410227
Annuals > 0 > cash Flow > net Change In Cash
-5351447517
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
0.4699999992691478
Annuals > 0 > ratios > PB
0.16680796881952503
Annuals > 0 > ratios > ROE
1.9599936305816201
Annuals > 0 > ratios > ROA
1.413076864837485
Annuals > 0 > ratios > FCF
740447407
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.11213598856812686
Annuals > 0 > health Score
61
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
7384039460
Annuals > 1 > income Statement > cost Of Revenue
4535510632
Annuals > 1 > income Statement > gross Profit
2848528828
Annuals > 1 > income Statement > operating Expenses
358416541
Annuals > 1 > income Statement > operating Income
2486940557
Annuals > 1 > income Statement > interest Expense
124134019
Annuals > 1 > income Statement > pretax Income
2488533058
Annuals > 1 > income Statement > net Income
2024849989
Annuals > 1 > income Statement > eps
2.3410062276881964
Annuals > 1 > income Statement > dividends Per Share
-589866946.69
Annuals > 1 > income Statement > shares Outstanding
864948570
Annuals > 1 > income Statement > income Tax Expense
338606214
Annuals > 1 > income Statement > EBITDA
2846507056
Annuals > 1 > income Statement > operating Margin
33.67994673473752
Annuals > 1 > income Statement > total Other Income Expense Net
1592501
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
7419991842
Annuals > 1 > balance Sheet > short Term Investments
42138295
Annuals > 1 > balance Sheet > receivables
3625350143
Annuals > 1 > balance Sheet > inventories
23397667
Annuals > 1 > balance Sheet > total Current Assets
11344141125
Annuals > 1 > balance Sheet > property Plant Equipment
1472607804
Annuals > 1 > balance Sheet > total Assets
29680742349
Annuals > 1 > balance Sheet > payables
249307924
Annuals > 1 > balance Sheet > short Term Debt
1969693500
Annuals > 1 > balance Sheet > long Term Debt
434223304.63
Annuals > 1 > balance Sheet > total Liabilities
5227180203
Annuals > 1 > balance Sheet > equity
21026774725
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
2024849991
Annuals > 1 > cash Flow > depreciation
305685451
Annuals > 1 > cash Flow > change In Working Capital
-849232407.71
Annuals > 1 > cash Flow > cash From Operations
1193878374
Annuals > 1 > cash Flow > capital Expenditures
313756832.07
Annuals > 1 > cash Flow > cash From Investing
-1896107964
Annuals > 1 > cash Flow > cash From Financing
-7806059
Annuals > 1 > cash Flow > net Change In Cash
-382799518
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
2.3410062276881964
Annuals > 1 > ratios > PB
0.16454231926908133
Annuals > 1 > ratios > ROE
9.629864853179473
Annuals > 1 > ratios > ROA
6.822100219700944
Annuals > 1 > ratios > FCF
880121541.9300001
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.11919242126178996
Annuals > 1 > health Score
73
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
7085471468
Annuals > 2 > income Statement > cost Of Revenue
4277007584
Annuals > 2 > income Statement > gross Profit
2808463884
Annuals > 2 > income Statement > operating Expenses
997689979
Annuals > 2 > income Statement > operating Income
2582398509
Annuals > 2 > income Statement > interest Expense
83178710
Annuals > 2 > income Statement > pretax Income
2585377423
Annuals > 2 > income Statement > net Income
2006552035
Annuals > 2 > income Statement > eps
2.320000001433703
Annuals > 2 > income Statement > dividends Per Share
-432462951
Annuals > 2 > income Statement > shares Outstanding
864893118
Annuals > 2 > income Statement > income Tax Expense
313651998
Annuals > 2 > income Statement > EBITDA
2953401404
Annuals > 2 > income Statement > operating Margin
36.44638921577547
Annuals > 2 > income Statement > total Other Income Expense Net
2978917
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
7858139864
Annuals > 2 > balance Sheet > short Term Investments
24945743
Annuals > 2 > balance Sheet > receivables
3031131172
Annuals > 2 > balance Sheet > inventories
22204440
Annuals > 2 > balance Sheet > total Current Assets
11107248144
Annuals > 2 > balance Sheet > property Plant Equipment
1326024503
Annuals > 2 > balance Sheet > total Assets
27446510596
Annuals > 2 > balance Sheet > payables
157957611
Annuals > 2 > balance Sheet > short Term Debt
1868214947
Annuals > 2 > balance Sheet > long Term Debt
244641137.61
Annuals > 2 > balance Sheet > total Liabilities
4765479654
Annuals > 2 > balance Sheet > equity
19583022331
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
2271725425
Annuals > 2 > cash Flow > depreciation
264745282
Annuals > 2 > cash Flow > change In Working Capital
-699141360.38
Annuals > 2 > cash Flow > cash From Operations
1357500892
Annuals > 2 > cash Flow > capital Expenditures
448603106.3
Annuals > 2 > cash Flow > cash From Investing
-2789365862.78
Annuals > 2 > cash Flow > cash From Financing
809253912
Annuals > 2 > cash Flow > net Change In Cash
-595676793
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
2.320000001433703
Annuals > 2 > ratios > PB
0.17666182540799555
Annuals > 2 > ratios > ROE
10.246385879995758
Annuals > 2 > ratios > ROA
7.310772813839697
Annuals > 2 > ratios > FCF
908897785.7
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.12827626076893264
Annuals > 2 > health Score
75
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
5213538054
Annuals > 3 > income Statement > cost Of Revenue
2942882997
Annuals > 3 > income Statement > gross Profit
2270655057
Annuals > 3 > income Statement > operating Expenses
892767123
Annuals > 3 > income Statement > operating Income
1919042935
Annuals > 3 > income Statement > interest Expense
24910069
Annuals > 3 > income Statement > pretax Income
3684565814
Annuals > 3 > income Statement > net Income
2874163020
Annuals > 3 > income Statement > eps
3.300000003444481
Annuals > 3 > income Statement > dividends Per Share
-261721027
Annuals > 3 > income Statement > shares Outstanding
870958490
Annuals > 3 > income Statement > income Tax Expense
292863592
Annuals > 3 > income Statement > EBITDA
3894660394
Annuals > 3 > income Statement > operating Margin
36.80884104274728
Annuals > 3 > income Statement > total Other Income Expense Net
1765522883
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
8544356169
Annuals > 3 > balance Sheet > short Term Investments
29180000
Annuals > 3 > balance Sheet > receivables
2101531368
Annuals > 3 > balance Sheet > inventories
6095078
Annuals > 3 > balance Sheet > total Current Assets
10851800756
Annuals > 3 > balance Sheet > property Plant Equipment
1123377370
Annuals > 3 > balance Sheet > total Assets
23741171551
Annuals > 3 > balance Sheet > payables
147866622
Annuals > 3 > balance Sheet > short Term Debt
492320000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
3135974351
Annuals > 3 > balance Sheet > equity
18123626117
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
3391702222
Annuals > 3 > cash Flow > depreciation
188922950
Annuals > 3 > cash Flow > change In Working Capital
-190959890.41
Annuals > 3 > cash Flow > cash From Operations
1423796250
Annuals > 3 > cash Flow > capital Expenditures
368619593.61
Annuals > 3 > cash Flow > cash From Investing
-2782684313.36
Annuals > 3 > cash Flow > cash From Financing
-163092602.81
Annuals > 3 > cash Flow > net Change In Cash
-1581545582
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
3.300000003444481
Annuals > 3 > ratios > PB
0.19222609965078435
Annuals > 3 > ratios > ROE
15.85865323774269
Annuals > 3 > ratios > ROA
12.106239213283212
Annuals > 3 > ratios > FCF
1055176656.39
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.20239166674547113
Annuals > 3 > health Score
89
Valuation > metrics > PE
26.6667
Valuation > metrics > PB
1.1577394911786623
Valuation > final Score
77.99996
Valuation > verdict
3.3% Overvalued
Profitability > metrics > ROE
2.9921551911789366
Profitability > metrics > ROA
9.97746412181323
Profitability > metrics > Net Margin
0.3588421859833059
Profitability > final Score
66
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.19251007210363244
Risk > metrics > Interest Coverage
13.049283930086053
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
5.498387064039673
Liquidity > metrics > Quick Ratio
5.460341011941333
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
70
Prev Profitabilities > 0
32
Prev Profitabilities > 1
26
Prev Profitabilities > 2
0
Prev Risks > 0
100
Prev Risks > 1
78
Prev Risks > 2
-8
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:58:42.488Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.1034
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0358
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.0263
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0657
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0517
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.0412
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0.0375
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0.023
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0.0777
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0.1339
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.0952
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.0647
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.07
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. It operates through Clinical Trial Solutions; and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. In addition, the company offers patient recruitment, investment management, medical registration, pharmaceuticals and regulations consulting, drug safety, bioequivalence, and third-party training services, as well as chemistry, management, and controls services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATigermed Officially Opens International Headquarters in Hong Kong marketscreener.com
Read more →(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Medium
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Hangzhou Tigermed Consulting Co. Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.1034
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.